Article

Thiazolidinones: Potential Human Novel Coronavirus (SARS-CoV-2) Protease Inhibitors Against COVID-19

2020-09-02

Abstract excerpt

COVID-19 is a rapidly spreading infectious disease caused by a novel beta coronavirus SARS-CoV-2. During the 1980's coronavirus, genomic RNA was transcribed into a set of subgenomic mRNAs that encode viral proteins containing a leader sequence derived from the 5' end of the genome. The subgenomic mRNAs are transcribed from negative-strand RNAs, synthesized for the full-length genomic RNA - a unique mechanism,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 06758220-d0fb-5a74-8325-1fb9a5098b07
DOI: 10.26434/chemrxiv.12891656.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thiazolidinones: Potential Human Novel Coronavirus (SARS-CoV-2) Protease Inhibitors Against COVID-19DOI 10.26434/chemrxiv.12891656.v2Read

The Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19Semantic proximity Read

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read

Novel inhibitors against COVID-19 main protease suppressed viral infectionSemantic proximity Read

Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screeningSemantic proximity Read

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Semantic proximity Read

Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19.Semantic proximity Read

Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studySemantic proximity Read

Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2Semantic proximity Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research StudySemantic proximity Read

Indole-based compounds as potential drug candidates for SARS-CoV-2Semantic proximity Read

Promising natural products against <scp>SARS‐CoV</scp>‐2: Structure, function, and clinical trialsSemantic proximity Read